Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Shenzhen Oculgen Biomedical Technology Co. Ltd.

Yihua Financial Technology Building No. 3939 Room 1201, Baishi Road, Binhai, Yuehai

About Specializations

Shenzhen Oculgen Biomedical Technology Co. Ltd. runs clinical trials in conditions such as Neovascular age-related macular degeneration, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Neovascular age-related macular degeneration

Not yet recruiting

Safety and Efficacy of Two Doses of OCUL101 Compared with Aflibercept in Patients with Neovascular Age‑Related Macular Degeneration

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:65+ years
  • Substances:Aflibercept
  • Sponsor:Shenzhen Oculgen Biomedical Technology Co. Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.